Prevalence of antimicrobial resistance in acute community-acquired urinary tract infections in Sub-Saharan Africa: a systematic review

  09 December 2025

This systematic review of 41 studies from 19 Sub-Saharan African countries found that antimicrobial resistance in community-acquired urinary tract infections is widespread and poorly documented, with major gaps in available data and inconsistent laboratory methods. Across more than 7,000 bacterial isolates, resistance to trimethoprim–sulfamethoxazole was extremely high in both E. coli (63%) and Klebsiella spp. (66%), while nitrofurantoin showed the lowest resistance levels, supporting its role as a first-line treatment. Resistance to ceftriaxone and ciprofloxacin was moderate, and no clear temporal or geographic patterns emerged due to substantial heterogeneity between studies. The findings highlight the need to reconsider empirical use of trimethoprim–sulfamethoxazole, strengthen laboratory standards and expand surveillance to better guide UTI management in the region.

Author(s): Amelia Williams-Walker et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!